MMP-3 appears to be involved in dopaminergic neurodegeneration, neuroinflammation and BBB integrity in PD; however, further studies will be required to clarify the role of all of these MMPs in PD and whether their specific inhibition could represent a valid therapeutic strategy. This evidence concerns the gene MMP3 and Parkinson disease.